0
USD
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Age-related Macular Degeneration (AMD) -Epidemiology Forecast to 2028
Published Date: March 2019
|
Report Code: DELV-Epid-122
Home | Market Reports |People & Society
Age related Macular Degeneration Epidemiology Forecast to 2028

Age-related Macular Degeneration (AMD) -Epidemiology Forecast to 2028

Code: DELV-Epid-122
Report
March 2019
50 Pages
Delveinsight
Region: Global,
Description
Table of Content
Tables & Figures

DelveInsight's "Age-related Macular Degeneration (AMD) - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Age-related Macular Degeneration (AMD) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2028

Age-related Macular Degeneration (AMD) Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Age-related Macular Degeneration (AMD) in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Age-related Macular Degeneration (AMD) outlook. It also includes the explanation of changing trends of epidemiology outlining the Age-related Macular Degeneration (AMD) scenario.

Age-related Macular Degeneration (AMD) Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Age-related Macular Degeneration (AMD) thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Age-related Macular Degeneration (AMD) explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Age-related Macular Degeneration (AMD) Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Age-related Macular Degeneration (AMD)

Key assessments
• Patient Segmentation in Age-related Macular Degeneration (AMD)
• Age-related Macular Degeneration (AMD) Risk & Burden
• Factors driving growth in a specific Age-related Macular Degeneration (AMD) patient population

1. Report Introduction
2. Age-related Macular Degeneration (AMD) Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Age-related Macular Degeneration (AMD) in 2016
2.2. Patient Share Distribution of Age-related Macular Degeneration (AMD) in 2028
3. Disease Background and Overview: Age-related Macular Degeneration (AMD)
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Age-related Macular Degeneration (AMD) in 7MM
4.3. Total Prevalent/ Incident Patient Population of Age-related Macular Degeneration (AMD) in 7MM – By Countries
5. Epidemiology of Age-related Macular Degeneration (AMD) by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD)
5.1.3. Sub-Type Specific cases of the Age-related Macular Degeneration (AMD) *
5.1.4. Sex- Specific Cases of the Age-related Macular Degeneration (AMD)*
5.1.5. Diagnosed Cases of the Age-related Macular Degeneration (AMD)
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD)
5.4.3. Sub-Type Specific cases of the Age-related Macular Degeneration (AMD)*
5.4.4. Sex- Specific Cases of the Age-related Macular Degeneration (AMD)*
5.4.5. Diagnosed Cases of the Age-related Macular Degeneration (AMD)
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD)
5.5.3. Sub-Type Specific cases of the Age-related Macular Degeneration (AMD)*
5.5.4. Sex- Specific Cases of the Age-related Macular Degeneration (AMD)*
5.5.5. Diagnosed Cases of the Age-related Macular Degeneration (AMD)
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD)
5.6.3. Sub-Type Specific cases of the Age-related Macular Degeneration (AMD)*
5.6.4. Sex- Specific Cases of the Age-related Macular Degeneration (AMD)*
5.6.5. Diagnosed Cases of the Age-related Macular Degeneration (AMD)
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD)
5.7.3. Sub-Type Specific cases of the Age-related Macular Degeneration (AMD)*
5.7.4. Sex- Specific Cases of the Age-related Macular Degeneration (AMD)*
5.7.5. Diagnosed Cases of the Age-related Macular Degeneration (AMD)
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD)
5.8.3. Sub-Type Specific cases of the Age-related Macular Degeneration (AMD)*
5.8.4. Sex- Specific Cases of the Age-related Macular Degeneration (AMD)*
5.8.5. Diagnosed Cases of the Age-related Macular Degeneration (AMD)
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD)
5.9.3. Sub-Type Specific cases of the Age-related Macular Degeneration (AMD)*
5.9.4. Sex- Specific Cases of the Age-related Macular Degeneration (AMD)*
5.9.5. Diagnosed Cases of the Age-related Macular Degeneration (AMD)
6. Unmet Needs of the Age-related Macular Degeneration (AMD)
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

LIST OF TABLES :

Table 1: Total Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD) in 7MM
Table 2: Total Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD) in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD) in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Age-related Macular Degeneration (AMD) in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Age-related Macular Degeneration (AMD) in United States (2016-2028)*
Table 6: Diagnosed Cases of the Age-related Macular Degeneration (AMD) in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD) in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Age-related Macular Degeneration (AMD) in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Age-related Macular Degeneration (AMD) in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Age-related Macular Degeneration (AMD) in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD) in France (2016-2028)
Table 12: Sub-Type Specific cases of the Age-related Macular Degeneration (AMD) in France (2016-2028) *
Table 13: Sex- Specific Cases of the Age-related Macular Degeneration (AMD) in France (2016-2028) *
Table 14: Diagnosed Cases of the Age-related Macular Degeneration (AMD) in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD) in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Age-related Macular Degeneration (AMD) in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Age-related Macular Degeneration (AMD) in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Age-related Macular Degeneration (AMD) in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD) in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Age-related Macular Degeneration (AMD) in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Age-related Macular Degeneration (AMD) in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Age-related Macular Degeneration (AMD) in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD) in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Age-related Macular Degeneration (AMD) in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Age-related Macular Degeneration (AMD) in UK (2016-2028) *
Table 26: Diagnosed Cases of the Age-related Macular Degeneration (AMD) in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD) in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Age-related Macular Degeneration (AMD) in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Age-related Macular Degeneration (AMD) in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Age-related Macular Degeneration (AMD) in Japan (2016-2028)

LIST OF FIGURES :

Figure 1: Total Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD) in 7MM
Figure 2: Total Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD) in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD) in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Age-related Macular Degeneration (AMD) in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Age-related Macular Degeneration (AMD) in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Age-related Macular Degeneration (AMD) in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD) in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Age-related Macular Degeneration (AMD) in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Age-related Macular Degeneration (AMD) in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Age-related Macular Degeneration (AMD) in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD) in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Age-related Macular Degeneration (AMD) in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Age-related Macular Degeneration (AMD) in France (2016-2028) *
Figure 14: Diagnosed Cases of the Age-related Macular Degeneration (AMD) in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD) in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Age-related Macular Degeneration (AMD) in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Age-related Macular Degeneration (AMD) in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Age-related Macular Degeneration (AMD) in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD) in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Age-related Macular Degeneration (AMD) in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Age-related Macular Degeneration (AMD) in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Age-related Macular Degeneration (AMD) in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD) in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Age-related Macular Degeneration (AMD) in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Age-related Macular Degeneration (AMD) in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Age-related Macular Degeneration (AMD) in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD) in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Age-related Macular Degeneration (AMD) in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Age-related Macular Degeneration (AMD) in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Age-related Macular Degeneration (AMD) in Japan (2016-2028)

DelveInsight's "Age-related Macular Degeneration (AMD) - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Age-related Macular Degeneration (AMD) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2028

Age-related Macular Degeneration (AMD) Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Age-related Macular Degeneration (AMD) in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Age-related Macular Degeneration (AMD) outlook. It also includes the explanation of changing trends of epidemiology outlining the Age-related Macular Degeneration (AMD) scenario.

Age-related Macular Degeneration (AMD) Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Age-related Macular Degeneration (AMD) thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Age-related Macular Degeneration (AMD) explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Age-related Macular Degeneration (AMD) Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Age-related Macular Degeneration (AMD)

Key assessments
• Patient Segmentation in Age-related Macular Degeneration (AMD)
• Age-related Macular Degeneration (AMD) Risk & Burden
• Factors driving growth in a specific Age-related Macular Degeneration (AMD) patient population

Read More

1. Report Introduction
2. Age-related Macular Degeneration (AMD) Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Age-related Macular Degeneration (AMD) in 2016
2.2. Patient Share Distribution of Age-related Macular Degeneration (AMD) in 2028
3. Disease Background and Overview: Age-related Macular Degeneration (AMD)
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Age-related Macular Degeneration (AMD) in 7MM
4.3. Total Prevalent/ Incident Patient Population of Age-related Macular Degeneration (AMD) in 7MM – By Countries
5. Epidemiology of Age-related Macular Degeneration (AMD) by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD)
5.1.3. Sub-Type Specific cases of the Age-related Macular Degeneration (AMD) *
5.1.4. Sex- Specific Cases of the Age-related Macular Degeneration (AMD)*
5.1.5. Diagnosed Cases of the Age-related Macular Degeneration (AMD)
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD)
5.4.3. Sub-Type Specific cases of the Age-related Macular Degeneration (AMD)*
5.4.4. Sex- Specific Cases of the Age-related Macular Degeneration (AMD)*
5.4.5. Diagnosed Cases of the Age-related Macular Degeneration (AMD)
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD)
5.5.3. Sub-Type Specific cases of the Age-related Macular Degeneration (AMD)*
5.5.4. Sex- Specific Cases of the Age-related Macular Degeneration (AMD)*
5.5.5. Diagnosed Cases of the Age-related Macular Degeneration (AMD)
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD)
5.6.3. Sub-Type Specific cases of the Age-related Macular Degeneration (AMD)*
5.6.4. Sex- Specific Cases of the Age-related Macular Degeneration (AMD)*
5.6.5. Diagnosed Cases of the Age-related Macular Degeneration (AMD)
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD)
5.7.3. Sub-Type Specific cases of the Age-related Macular Degeneration (AMD)*
5.7.4. Sex- Specific Cases of the Age-related Macular Degeneration (AMD)*
5.7.5. Diagnosed Cases of the Age-related Macular Degeneration (AMD)
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD)
5.8.3. Sub-Type Specific cases of the Age-related Macular Degeneration (AMD)*
5.8.4. Sex- Specific Cases of the Age-related Macular Degeneration (AMD)*
5.8.5. Diagnosed Cases of the Age-related Macular Degeneration (AMD)
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD)
5.9.3. Sub-Type Specific cases of the Age-related Macular Degeneration (AMD)*
5.9.4. Sex- Specific Cases of the Age-related Macular Degeneration (AMD)*
5.9.5. Diagnosed Cases of the Age-related Macular Degeneration (AMD)
6. Unmet Needs of the Age-related Macular Degeneration (AMD)
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

Read More

LIST OF TABLES :

Table 1: Total Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD) in 7MM
Table 2: Total Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD) in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD) in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Age-related Macular Degeneration (AMD) in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Age-related Macular Degeneration (AMD) in United States (2016-2028)*
Table 6: Diagnosed Cases of the Age-related Macular Degeneration (AMD) in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD) in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Age-related Macular Degeneration (AMD) in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Age-related Macular Degeneration (AMD) in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Age-related Macular Degeneration (AMD) in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD) in France (2016-2028)
Table 12: Sub-Type Specific cases of the Age-related Macular Degeneration (AMD) in France (2016-2028) *
Table 13: Sex- Specific Cases of the Age-related Macular Degeneration (AMD) in France (2016-2028) *
Table 14: Diagnosed Cases of the Age-related Macular Degeneration (AMD) in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD) in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Age-related Macular Degeneration (AMD) in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Age-related Macular Degeneration (AMD) in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Age-related Macular Degeneration (AMD) in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD) in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Age-related Macular Degeneration (AMD) in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Age-related Macular Degeneration (AMD) in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Age-related Macular Degeneration (AMD) in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD) in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Age-related Macular Degeneration (AMD) in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Age-related Macular Degeneration (AMD) in UK (2016-2028) *
Table 26: Diagnosed Cases of the Age-related Macular Degeneration (AMD) in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD) in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Age-related Macular Degeneration (AMD) in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Age-related Macular Degeneration (AMD) in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Age-related Macular Degeneration (AMD) in Japan (2016-2028)

LIST OF FIGURES :

Figure 1: Total Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD) in 7MM
Figure 2: Total Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD) in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD) in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Age-related Macular Degeneration (AMD) in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Age-related Macular Degeneration (AMD) in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Age-related Macular Degeneration (AMD) in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD) in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Age-related Macular Degeneration (AMD) in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Age-related Macular Degeneration (AMD) in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Age-related Macular Degeneration (AMD) in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD) in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Age-related Macular Degeneration (AMD) in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Age-related Macular Degeneration (AMD) in France (2016-2028) *
Figure 14: Diagnosed Cases of the Age-related Macular Degeneration (AMD) in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD) in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Age-related Macular Degeneration (AMD) in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Age-related Macular Degeneration (AMD) in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Age-related Macular Degeneration (AMD) in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD) in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Age-related Macular Degeneration (AMD) in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Age-related Macular Degeneration (AMD) in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Age-related Macular Degeneration (AMD) in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD) in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Age-related Macular Degeneration (AMD) in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Age-related Macular Degeneration (AMD) in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Age-related Macular Degeneration (AMD) in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Age-related Macular Degeneration (AMD) in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Age-related Macular Degeneration (AMD) in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Age-related Macular Degeneration (AMD) in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Age-related Macular Degeneration (AMD) in Japan (2016-2028)

Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$3250
This license allows only one user to access the PDF.

Site License

Electronic (PDF)
$6500
This license allows all the users of an enterprise residing in one location to access the PDF

Enterprise License

Electronic (PDF)
$9750
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SIS Group of Schools

RELATED REPORTS

Global Companion Animal Internal Dewormer Market Research Report 2021
Global Companion Animal Internal Dewormer Market Research Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-11T1107
Tue Jun 15 00:00:00 UTC 2021

Add to Cart

Global Water Pollution Control Sales Market Report 2021
Global Water Pollution Control Sales Market Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-36P5183
Tue Jun 15 00:00:00 UTC 2021

Add to Cart

Global Kids Lamps Sales Market Report 2021
Global Kids' Lamps Sales Market Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-37O5183
Tue Jun 15 00:00:00 UTC 2021

Add to Cart

Global Environmental Remediation Services Market Size Status and Forecast 2021 2027
Global Environmental Remediation Services Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-1O5566
Tue Jun 15 00:00:00 UTC 2021

Add to Cart

0 Items
X
No items in the cart.
$0.0